Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Jul 10, 2020
3 Stocks to Buy if Coronavirus Second Wave Hits

3 Stocks to Buy if Coronavirus Second Wave Hits

Will there be a second wave? Scientists around the world are evaluating that question out of concern for public health. Investors want to know what it means for their portfolios. Which stocks will do well if Coronavirus spikes again? Tickeron can give you some insight on that. By analyzing market trends from the first wave, you can predict behavior for the second.

Technology stocks have performed at historic levels this year, but the market is severely overbought. Third quarter earnings reports may bring some of those numbers back to earth. To compensate for that, look at performance during Q1 and Q2, the height of global Covid shutdowns. You should also evaluate twelve-month trends and sales projections for Q3.

Netflix will Continue to Climb

On January 1st, Netflix (NFLX) was trading at $323.57 a share. It bottomed out on March 16th, when it hit a 2020 low of $298.84. The virus was just beginning to impact the US economy. By mid-April, the US and all other affected countries were completely shut down. Netflix stock benefitted from the stay-at-home orders. It’s currently selling for over $500 per share. 

Tickeron Screener has Netflix listed as a strong buy, with a projection of bullish behavior in both the one-week and one-month categories. The one-year historical analysis shows a market cap gain of 33.05%. Yahoo Finance predicts that sales growth for the third quarter will be 21.60%. That’s pretty good, but another Coronavirus wave could make that number climb even higher.

Technical analysis shows that Netflix is definitely a buy, but does fundamental analysis agree? Some might argue that Amazon Prime is gobbling up all the market share, but Netflix is producing original content at a faster rate. Viewers need fresh content. Movie theatres aren’t re-opening any time soon, if ever. Netflix is a definite buy if we see a second wave.   

Amazon is the 300-Pound Gorilla in 2020

Sure, Tesla (TSLA) has made a lot of noise this year, but we’re not betting on them to thrive during a second wave. It’s possible that they are the most overbought stock of 2020. Amazon (AMZN), on the other hand, is a beast. After an annual low of $1849.09 on March 20th, Jeff Bezos’ brainchild has skyrocketed to over $3000 per share, an all-time high. 

Needless to say, Tickeron has Amazon listed as a strong buy as 3 major fundamental metrics are signaling for a bullish momentum: Profit VS Risk rating, Price Growth rating, P/E Growth rating. 

Yahoo Finance predicts Q3 sales growth at 22.20%. The one-year market cap growth is an astounding 58.42%. Those are King Kong sized numbers. They also make Amazon an unstoppable force, even if Covid-19 strikes again. That second wave may actually turn their growth rate into a tsunami. 

You don’t have to be a financial analyst to see this one. Between Amazon Prime Video and their online shopping platform, the FAANG giant holds all the cards if the world goes into shut-down mode again. Even if that doesn’t happen, the way people shop and live their lives has changed forever after the first wave. Amazon is in the best position to take advantage of that.  

Zoom has Outpaced Google Meet

It’s rare to see Google lose a fight, but they can throw in the towel on this one. Zoom (ZM) has outperformed them this year in every way. Surprisingly, the area that Google Meet fell short was user experience. They were simply unprepared for the sheer volume of users that descended upon them when the world went virtual. Zoom was ready for it.  

In the past six months, Zoom’s stock has shown a gain of 267%. Q2 earnings actually exceeded expectations, which were fairly high. Tickeron has it listed as a buy, not a strong buy, but the 200% annual increase in market cap suggests it may be undervalued. Increased usage in the corporate and government sectors also indicate a spike will happen if a second wave hits.

Zoom’s movement in the past few weeks has been somewhat volatile, so if you’re trading, go long. Or buy some call options. The Aroon Indicator entered an uptrend on July 7th, so neither strategy will hurt you. Video conferencing is the preferred method of communication going forward and Zoom is the clear leader in the field. This stock will thrive in Q3. 

Current price $269.52 is above $255.90 the highest resistance line found by A.I. Throughout the month of 06/07/20 - 07/08/20, the price experienced a +28% Uptrend. During the week of 06/30/20 - 07/08/20, the stock enjoyed a +4% Uptrend growth.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In 61 of 72 similar cases where ZM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.

 

Use Tickeron Ticker for Additional Research

You can look up any publicly traded stock by going to the Tickeron Ticker page and entering the trading ticker for that security. Most of the information we’ve provided you here comes from those pages and Tickeron Screener. Check out both today to be a more informed trader or long-term investor. It’s free to get started and there are training and practice tools for the newbie.  

Related Ticker: ZM

ZM's RSI Indicator ascends from oversold territory

The RSI Oscillator for ZM moved out of oversold territory on June 26, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 40 similar instances when the indicator left oversold territory. In of the 40 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 31, 2026. You may want to consider a long position or call options on ZM as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ZM just turned positive on July 27, 2026. Looking at past instances where ZM's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

ZM moved above its 50-day moving average on July 31, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZM advanced for three days, in of 288 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 186 cases where ZM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ZM broke above its upper Bollinger Band on July 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ZM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.889) is normal, around the industry mean (26.944). P/E Ratio (14.470) is within average values for comparable stocks, (78.990). ZM's Projected Growth (PEG Ratio) (4.214) is slightly higher than the industry average of (1.637). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (6.057) is also within normal values, averaging (51.731).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Salesforce (NYSE:CRM), Shopify Inc (NASDAQ:SHOP), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Datadog (NASDAQ:DDOG), Intuit (NASDAQ:INTU), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Zoom Communications Inc (NASDAQ:ZM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 11.28B. The market cap for tickers in the group ranges from 291 to 392.13B. QH holds the highest valuation in this group at 392.13B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 3%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 1%. FUSE experienced the highest price growth at 55%, while YAAS experienced the biggest fall at -87%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was 5%. For the same stocks of the Industry, the average monthly volume growth was -13% and the average quarterly volume growth was -41%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 78
Price Growth Rating: 61
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
ZM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of video-first communications platform and application

Industry PackagedSoftware

Profile
Details
Industry
Packaged Software
Address
55 Almaden Boulevard
Phone
+1 888 799-9666
Employees
7420
Web
https://www.zoom.com
Interact to see
Advertisement
Chevron’s upcoming Q4 report highlights its first full quarters integrating Hess, following record Q3 production of 4.1 million barrels of oil equivalent per day (MMboe/d). Comparing CVX with ExxonMobil and Shell provides insight into how each supermajor is navigating a volatile oil market with prices hovering below $60 per barrel.
SoFi Technologies is set to report Q4 and full-year 2025 earnings on January 30, 2026, closing out a pivotal year for the digital finance platform. With its fiscal year ending December 31, the report follows a strong Q3 that featured record net revenue of $962 million and member growth to 12.6 million, a 35% year-over-year increase.
ASML reported Q4 2025 net sales of $9.7 billion, gross margin of 52.2%, net income of $2.8 billion, and record net bookings of $13.2 billion, including $7.4 billion in EUV orders.
IDEXX Laboratories (IDXX) reports Q4 2025 earnings on February 2, 2026, with analysts expecting continued strength in recurring revenue from companion animal diagnostics. Danaher (DHR) reports on January 28, while Thermo Fisher Scientific (TMO) follows in early February, with both facing low-single-digit core growth expectations across life sciences and diagnostics.
NIO Inc. (NIO) produced its one-millionth vehicle this week at its Hefei facility, closing out a record 2025 delivery total of 326,028 units, up 46.9% year over year. The milestone, announced January 6, reflects accelerating demand for core models such as the ES8 SUV and newer brands ONVO and Firefly.
Faraday Future Intelligent Electric Inc. (FFAI) shares traded near $1.02 this week following announcements of a non-binding $10 million stock purchase term sheet with AIxCrypto (AIxC) and preparations for a Stockholders’ Day on January 7, 2026. Trading volume spiked amid broader EV volatility, highlighting investor attention on FFAI’s pivot toward AI-enhanced mobility and robotics.
BTQ Technologies Corp. (BTQ), formerly BTQQF, launched the Bitcoin Quantum testnet this week—the first quantum-safe Bitcoin fork, 17 years after Bitcoin’s genesis block. The move coincided with inclusion in the $524.5 million VanEck Quantum Computing UCITS ETF, boosting European investor visibility.
VEU targets large- and mid-cap ex-U.S. stocks with ~3,800 holdings. VXUS offers broad all-cap exposure, including ~8,600 stocks across small-, mid-, and large-cap companies.
Apple (AAPL) reports Q1 FY2026 earnings on January 29, with consensus revenue at $138.5B and EPS at $2.67, supported by strong demand for iPhone 17 models, higher average selling prices, and continued Services growth. Microsoft (MSFT) reports Q2 FY2026 on January 28, expecting $80.3B revenue and $3.91 EPS, driven by Azure AI adoption and enterprise cloud expansion, though elevated capex spending (~$35B/quarter) remains under scrutiny.
Visa Inc. (V), the global payments network leader, reports Q1 FY2026 earnings on January 29, 2026, for the period ending December 31, 2025. This marks the start of FY2026 following a strong FY2025, where net revenue reached $40 billion (+11%) and EPS climbed to $11.47 (+14%). Investors are watching closely for insights into consumer spending, cross-border travel recovery, and digital payment adoption.
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.